Free Trial

Passage Bio (PASG) SEC Filings & 10K Form

Passage Bio logo
$0.52 -0.07 (-11.88%)
(As of 11/15/2024 ET)

Recent Passage Bio SEC Filings

DateFilerForm TypeView
11/14/2024
4:21 PM
Erste Asset Management GmbH (Filed by)
Passage Bio (Subject)
Form SCHEDULE 13G/A
11/13/2024
6:15 AM
Passage Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
3:41 PM
Cale Edgar B. (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:51 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
5:38 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:36 PM
ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
7:38 PM
ORBIMED CAPITAL LLC (Reporting)
Passage Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
3:15 PM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
6:06 PM
Passage Bio (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SC 13D/A
08/09/2024
4:11 PM
Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2024
4:15 PM
Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
Form SC 13G/A
08/08/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:15 AM
Passage Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
6:01 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
3:35 PM
Passage Bio (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SC 13D/A
05/23/2024
4:43 PM
Countouriotis Athena (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
3:51 PM
Passage Bio (Issuer)
Porter Derrell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
3:52 PM
Passage Bio (Issuer)
Sondhi Dolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
3:53 PM
Islam Saqib (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
3:55 PM
Kapadia Sandip (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
3:56 PM
GOWEN MAXINE (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
7:15 AM
Passage Bio (Filer)
Form 424B3
05/14/2024
6:01 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
6:15 AM
Passage Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/16/2024
11:15 PM
Passage Bio (Filer)
Form EFFECT
04/12/2024
4:35 PM
ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
Form SC 13D/A
04/09/2024
8:35 AM
Passage Bio (Filer)
Form DEFA14A
04/09/2024
5:00 AM
Passage Bio (Filer)
Form ARS
04/09/2024
5:02 AM
Passage Bio (Filer)
Form DEF 14A
03/29/2024
3:15 PM
Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
Form SC 13G
03/04/2024
6:15 AM
Passage Bio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2024
6:02 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
3:06 PM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
8:21 AM
Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
Form SC 13G/A
02/13/2024
6:34 PM
Forman Mark S (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
6:36 PM
Borthwick Kathleen (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
5 Stocks that could triple in a week (Ad)

Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.

Click here to pay just $5 for a full year of Stealth Trades
12/29/2023
3:15 PM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
6:05 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PASG) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners